hARIP2 is a putative growth-promoting factor involved in human colon tumorigenesis

Rui-Feng Gao1, Zhan-Dong Li, Jing Jiang

  • 1Changchun University of Science and Technology, Changchun, China E-mail : nszhang9@sina.com, hltiet@163.com, rumeng2215137@163.com.

Insights

Human activin receptor-interacting protein 2 (hARIP2) promotes colon cancer growth and is highly expressed in malignant tissues. This suggests hARIP2 may be a predictive marker for colon carcinoma aggressiveness.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Activin, a TGF-β superfamily member, inhibits colon cancer cell proliferation.
  • Human activin receptor-interacting protein 2 (hARIP2) negatively regulates activin signaling.
  • The role of hARIP2 in colon cancer remains underexplored.

Purpose of the Study:

  • To investigate the role and significance of hARIP2 in human colon cancer.

Main Methods:

  • In vitro studies using colon cancer cell lines (HCT8, SW620) with hARIP2 overexpression.
  • In vivo analysis using immunohistochemistry on human colon tissues.

Main Results:

  • hARIP2 overexpression reduced activin signaling, enhanced cell proliferation, and colony formation in vitro.
  • hARIP2 promoted colon cancer cell apoptosis, indicating a role in early carcinogenesis.
  • hARIP2 expression was significantly higher in malignant colon tissues compared to controls.

Conclusions:

  • hARIP2 plays a role in human colon tumorigenesis.
  • hARIP2 expression levels may serve as a predictive marker for colon carcinoma aggressiveness.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.1K
Tumor Progression02:07

Tumor Progression

3.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
3.8K